The vasoregulatory role of endothelium derived nitric oxide during pulsatile cardiopulmonary bypass

被引:11
|
作者
Macha, M [1 ]
Yamazaki, K [1 ]
Gordon, LM [1 ]
Watach, MJ [1 ]
Konishi, H [1 ]
Billiar, TR [1 ]
Borovetz, HS [1 ]
Kormos, RL [1 ]
Griffith, BP [1 ]
Hattler, BG [1 ]
机构
[1] UNIV PITTSBURGH,MED CTR,ARTIFICIAL HEART & LUNG PROGRAM,DIV CARDIOTHORAC SURG,PITTSBURGH,PA 15219
关键词
D O I
10.1097/00002480-199609000-00101
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The role of pulsatile flow as a physiologic stimulus for endothelium mediated vasoregulation is poorly understood. Furthermore, non pulsatile flow, which is associated with increased vascular resistance and end-organ failure, has been demonstrated to lead to a decrease in nitric oxide (NO) production in vitro. Anesthetized pigs (23.4 +/- 0.3 kg) were placed on cardiopulmonary bypass using either non pulsatile or pulsatile perfusion for 60 min. In both groups, animals were maintained with a constant mean aortic flow (1.0-1.3 L/min). Serum samples obtained during bypass were assayed for the stable end-products of NO (nitrate [NO3-] and nitrite [NO2-]) by a method based on the Greiss reaction. Systemic vascular resistance was higher after 60 min in the non pulsatile (3712.5 +/- 481.2 dyne sec cm(-5)) vs the pulsatile group (2672.6 +/- 427.0 dyne sec cm(-5)), but not statistically significant (p > .05). However, NO production was decreased in the non pulsatile flow group (27 +/- 6%) vs the pulsatile flow group (14 +/- 5%) at a statistically significant level (p < .005). The results suggest that non pulsatile flow is associated with diminished endothelial shear stress and a reduction in endothelial nitric oxide production. This may contribute to the detrimental physiologic effects observed in prolonged non pulsatile flow states.
引用
收藏
页码:M800 / M804
页数:5
相关论文
共 50 条
  • [21] THE VARIATIONS OF HEMODYNAMICS DURING PULSATILE CARDIOPULMONARY BYPASS
    TOMINO, T
    UMEZU, M
    ARTIFICIAL ORGANS, 1981, 5 (03) : 314 - 314
  • [22] PULSATILE FLOW DURING ROUTINE CARDIOPULMONARY BYPASS
    CHIU, IS
    CHU, SH
    HUNG, CR
    JOURNAL OF CARDIOVASCULAR SURGERY, 1984, 25 (06): : 530 - 537
  • [23] Pulsatile Flow During Cardiopulmonary Bypass in Children
    Karl, Tom R.
    ANNALS OF THORACIC SURGERY, 2022, 114 (04): : 1411 - 1411
  • [24] Pro: Pulsatile Flow During Cardiopulmonary Bypass
    Bertini, Pietro
    Guarracino, Fabio
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (11) : 2370 - 2373
  • [25] Role of nitric oxide in placental dysfunction following fetal cardiopulmonary bypass
    Lam, Christopher
    Baker, R. Scott
    Lubbers, Walter C.
    Spezzano, Lawrence C.
    Teuschler, Catie
    McNamara, Jerri L.
    Ferguson, Robert E.
    Gardner, Aimee
    Lombardi, John P.
    Clark, Kenneth E.
    Eghtesady, Pirooz
    CIRCULATION, 2006, 114 (18) : 585 - 585
  • [26] Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass
    Hill, GE
    Springall, DR
    Robbins, RA
    SURGERY, 1997, 121 (04) : 449 - 455
  • [27] The impact of exogenous nitric oxide during cardiopulmonary bypass for cardiac surgery
    Mc Loughlin, Joseph
    Browne, Lorraine
    Hinchion, John
    PERFUSION-UK, 2022, 37 (07): : 656 - 667
  • [28] Effect of diabetes on nitric oxide (NO) production during cardiopulmonary bypass (CPB)
    Matata, BM
    Goodall, AH
    Sosnowski, AW
    de Bono, D
    Galinanes, M
    FASEB JOURNAL, 1998, 12 (05): : A799 - A799
  • [29] Nitric oxide, L-arginine, hypertension and cardiopulmonary bypass - Three case reports - Nitric oxide and cardiopulmonary bypass
    Xabregas, A
    Stokes, J
    ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY, 1995, 5 (04): : 231 - 236
  • [30] PULSATILE FLOW DURING CARDIOPULMONARY BYPASS - EVALUATION OF A NEW PULSATILE PUMP
    WAABEN, J
    ANDERSEN, K
    HUSUM, B
    SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1985, 19 (02): : 149 - 153